OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
331A56

Medix Inc

Advertising & MarketingVerified

Medix Inc maintains a strong liquidity position, with a current ratio of 2.15 and cash and equivalents amounting to ¥3.77 billion, which significantly exceeds its total liabilities of ¥3.4 billion. The company's liquidity_fpt indicates a low liquidity risk, supported by a robust operating cash flow of ¥499.95 million and free cash flow of ¥771.60 million. In terms of profitability, Medix Inc demonstrates a return on equity (ROE) of 24.59% and a return on assets (ROA) of 12.05%, both of which are strong indicators of efficient capital utilization and profitability. These figures are well above the typical thresholds for the Advertising & Marketing industry, suggesting that the company is outperforming its peers in generating returns from its equity and assets. The company operates through a single business segment, the Digital Marketing Support business, and its geographic exposure is concentrated in Japan. There is no indication of significant international operations or revenue diversification, which may expose the company to regional economic fluctuations. Looking at the growth trajectory, Medix Inc has shown consistent revenue growth, with a current revenue of ¥4.16 billion. The outlook for the current fiscal year indicates a positive direction, with expected revenue growth driven by continued demand for digital marketing services. The company's focus on performance-based advertising and integrated digital marketing planning positions it well to capitalize on market trends. The risk assessment for Medix Inc indicates a low risk of dilution and no immediate filing-based liquidity or dilution flags. The company's debt-to-equity ratio is 0.04, reflecting a conservative capital structure with minimal long-term debt exposure. This low leverage supports the company's financial stability and reduces the risk of financial distress. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company continues to focus on its core digital marketing services, with no major restructuring or strategic shifts reported in the latest filings. The absence of dilution risks and the company's strong liquidity position suggest a stable and predictable financial outlook.

30-day price · 331A(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyMedix Inc
Ticker331A.T
SectorConsumer Cyclicals
BusinessCyclical Consumer Services
Industry groupCyclical Consumer Services
IndustryAdvertising & Marketing
AI analysis

Business. Medix Inc is a Japan-based company primarily engaged in the digital marketing support business, providing a variety of services to support the marketing of client companies through Internet advertising sales, marketing digital transformation (DX) / access analysis, website development, and other services.

Classification. Medix Inc is classified under the Advertising & Marketing industry within the Consumer Cyclicals economic sector and the Cyclical Consumer Services business sector, with a classification confidence of 0.92.

Medix Inc maintains a strong liquidity position, with a current ratio of 2.15 and cash and equivalents amounting to ¥3.77 billion, which significantly exceeds its total liabilities of ¥3.4 billion. The company's liquidity_fpt indicates a low liquidity risk, supported by a robust operating cash flow of ¥499.95 million and free cash flow of ¥771.60 million. In terms of profitability, Medix Inc demonstrates a return on equity (ROE) of 24.59% and a return on assets (ROA) of 12.05%, both of which are strong indicators of efficient capital utilization and profitability. These figures are well above the typical thresholds for the Advertising & Marketing industry, suggesting that the company is outperforming its peers in generating returns from its equity and assets. The company operates through a single business segment, the Digital Marketing Support business, and its geographic exposure is concentrated in Japan. There is no indication of significant international operations or revenue diversification, which may expose the company to regional economic fluctuations. Looking at the growth trajectory, Medix Inc has shown consistent revenue growth, with a current revenue of ¥4.16 billion. The outlook for the current fiscal year indicates a positive direction, with expected revenue growth driven by continued demand for digital marketing services. The company's focus on performance-based advertising and integrated digital marketing planning positions it well to capitalize on market trends. The risk assessment for Medix Inc indicates a low risk of dilution and no immediate filing-based liquidity or dilution flags. The company's debt-to-equity ratio is 0.04, reflecting a conservative capital structure with minimal long-term debt exposure. This low leverage supports the company's financial stability and reduces the risk of financial distress. Recent events and filings do not indicate any significant changes in the company's operations or financial strategy. The company continues to focus on its core digital marketing services, with no major restructuring or strategic shifts reported in the latest filings. The absence of dilution risks and the company's strong liquidity position suggest a stable and predictable financial outlook.
Key takeaways
  • Medix Inc maintains a strong liquidity position with a current ratio of 2.15 and significant cash reserves.
  • The company demonstrates high profitability with a return on equity of 24.59% and a return on assets of 12.05%.
  • Medix Inc operates through a single business segment and is geographically concentrated in Japan.
  • The company's growth trajectory is positive, driven by continued demand for digital marketing services.
  • The risk assessment indicates a low risk of dilution and a conservative capital structure with minimal long-term debt.
  • --
  • # RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$4.16B
Gross profit$3.73B
Operating income$802.6M
Net income$803.7M
R&D
SG&A
D&A
SBC
Operating cash flow$499.9M
CapEx-$17.2M
Free cash flow$771.6M
Total assets$6.67B
Total liabilities$3.40B
Total equity$3.27B
Cash & equivalents$3.77B
Long-term debt$122.0M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.27B
Net cash$3.65B
Current ratio2.1
Debt/Equity0.0
ROA12.0%
ROE24.6%
Cash conversion62.0%
CapEx/Revenue-0.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Advertising & Marketing · cohort 1 companies
Metric331AActivity
Op margin19.3%2.0% medp25 2.0% · p75 2.0%top quartile
Net margin19.3%-8.4% medp25 -8.4% · p75 -8.4%top quartile
Gross margin89.6%38.6% medp25 20.9% · p75 59.0%top quartile
CapEx / revenue-0.4%0.8% medp25 0.8% · p75 0.8%bottom quartile
Debt / equity4.0%354.4% medp25 354.4% · p75 354.4%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 00:31 UTC#76e1757e
Market quoteclose JPY 487.00 · shares 0.01B diluted
no public URL
2026-05-07 00:31 UTC#7efa6b05
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 20:49 UTCJob: 317c6363